MAGNA™ is a revolutionary single molecular analysis platform that offers a powerful new way to probe complex biomolecular interactions, unlocking critical and unique structural insights.
Bringing the dynamic genome to life.
MAGNA™ reveals complex biomolecular interactions,delivering new ways of detecting and treating disease
Learn more about MAGNA™About Depixus®
Depixus® is a fast-growing life science tools company, based in France and the UK, developing a state-of-the-art platform technology with applications spanning drug development and biological research.
Our Technology
MAGNA™ is a revolutionary single molecule analysis platform that offers a powerful new way to probe complex biomolecular interactions. Based on established magnetic tweezer technology, MAGNA™ precisely measures changes in the biophysical properties of individual three-dimensional molecular structures, in real time, capturing vital information about binding events and their impact on structural dynamics, binding kinetics and mechanism of action.
News
Stay up to date with news from Depixus® and our team. Read our latest press releases, blog, the scientific conferences we will be participating in, upcoming webinars and latest job announcements.
FRANCE
3-5 impasse Reille, 75014 Paris,
France
UNITED KINGDOM
Harston Mill Royston RD Harston
Cambridge CB22 7GG, UK
